Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
Completed
- Conditions
- Asthma
- Registration Number
- NCT00573222
- Lead Sponsor
- AstraZeneca
- Brief Summary
This is a 3-month non-interventional, observational study on patients with moderate and severe asthma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 330
Inclusion Criteria
- Patients with moderate and severe asthma on Symbicort SMART treatment
Exclusion Criteria
- Under 18 years old
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate & describe asthma control in adult patients w/moderate to severe asthma treated w/Symbicort SMART following the frequency, type & severity of symptoms through the Asthma Control Questionnaire.
- Secondary Outcome Measures
Name Time Method to evaluate the safety of Symbicort SMART treatment through the number and type of reported adverse events 2. assessment of patient's satisfaction with the treatment 3.assessment of physician's satisfaction with the treatment
Trial Locations
- Locations (2)
Research Site
🇭🇷Zagreb, Croatia
Croatia
🇭🇷Zadar, Croatia